- Remimazolam in intensive care unit🔍
- Review of remimazolam and sedatives in the intensive care unit🔍
- Remimazolam tosylate's long|term sedative properties in ICU ...🔍
- Remimazolam besylate for the sedation of postoperative patients ...🔍
- Long|term sedation with remimazolam besylate versus propofol in ...🔍
- Remimazolam🔍
- Remimazolam – current status🔍
- Remimazolam besylate versus propofol for long|term sedation ...🔍
Remimazolam in intensive care unit
Remimazolam in intensive care unit: Potential applications and ...
It also has comparable deep sedation properties to propofol in the ICU. Furthermore, it reduces post-procedural delirium and patient comfort and ...
Review of remimazolam and sedatives in the intensive care unit - PMC
Remimazolam is a novel intravenous ultra-short acting benzodiazepine that has the potential of being a safe and effective new sedative for ...
Remimazolam tosylate's long-term sedative properties in ICU ...
This study compared remimazolam tosylate with propofol or midazolam to assess its safety and effectiveness for long-term sedation of intensive care unit (ICU) ...
Remimazolam besylate for the sedation of postoperative patients ...
Remimazolam besylate was effective for mild/moderate sedation of invasively mechanically ventilated postoperative patients in the ICU while maintaining ...
Con: Remimazolam – The new miracle cure for critically ill patients
Remimazolam is gaining recognition as a promising sedative for patients in the intensive care unit (ICU).
Remimazolam in intensive care unit: Potential applications and ...
Remimazolam shows promise for sedation in the ICU, offering rapid onset and offset of action and precise titration of sedation levels. Its use ...
Con: Remimazolam – The new miracle cure for critically ill patients
Remimazolam is gaining recognition as a promising sedative for patients in the intensive care unit (ICU).
Long-term sedation with remimazolam besylate versus propofol in ...
Remimazolam besylate has a fast and short-acting characteristic similar to propofol and is expected to be a similarly effective sedative in the ...
Remimazolam: A New Ingress in Cardiac Surgical Intensive Care Unit
Abstract. Remimazolam is a novel intravenous ultrashort acting benzodiazepine that has a potential for safe and effective sedative. This recent addition in ...
Remimazolam – current status, opportunities and challenges
Doi and co-workers used remimazolam to induce and maintain anaesthesia in surgical patients of American Society of Anesthesiologists physical ...
Remimazolam besylate versus propofol for long-term sedation ...
Remimazolam besylate may be an effective and safe sedative in mechanically ventilated ICU patients for long-term sedation. This study found that ...
Efficacy and Safety of Remimazolam Tosylate for Sedation in ICU ...
This study was conducted to confirm the efficacy and safety of remimazolam and search for the optimal dosage for light sedation (RASS + 1 to − 2) in patients ...
Efficacy and Safety of Remimazolam Tosilate Combined ... - Frontiers
Remimazolam tosilate has many potential clinical advantages, such as effective relief of anxiety and restlessness during ICU treatment, stable ...
Remimazolam: pharmacological characteristics and clinical ...
Remimazolam for anesthesia and sedation. Page 8. Remimazolam for intensive care unit (ICU) sedation. Because ICU patients are critically ill with essential ...
(PDF) Remimazolam tosylate's long-term sedative properties in ICU ...
Background: Remimazolam is a novel ultra-short-acting sedative, but its safety and adverse events (AEs) in high-risk patients in the intensive ...
Remimazolam besylate for sedation of postoperative patients
On admission into our ICU, an included patient received a continuous infusion of sufentanil at 0.2 to 0.3 μg·kg −1·h −1 for analgesia. When the Richmond ...
Remimazolam in intensive care unit: Potential applications and ...
In conclusion, Remimazolam is an excellent alternative to current sedatives and anesthetics in the ICU. Its cost is comparable to that of ...
Search - ACC : Acute and Critical Care
Basic science and research; Review of remimazolam and sedatives in the intensive care unit: Hey-Ran Choi, In-Ae Song: Acute Crit Care. 2022;37(2):151-158.
RemImazolam Besylate for ICU-sedation in Patients With ...
Remimazolam, as a short-acting sedative agent that is not metabolized by liver or kidney, can achieve rapid and reversible sedation and has the ...
Remimazolam in intensive care unit: Potential applications and ...
This manuscript explores the potential use of Remimazolam in the intensive care unit (ICU) and critical care units, considering its pharmacological ...